In a nuclear or radiological incident, first responders must quickly measure the radiation exposure of a large number of individuals, since treatment options are radiation dose-dependent and time-sensitive. SRI is developing a biodosimeter to meet this critical challenge.
Together with GexCon US, SRI is designing and conducting experiments to improve and validate tools used to minimize the risk of explosions or fires on offshore platforms.
Innovative Science Overcomes Formulation Challenges
A new oral version of a known chelating agent can defend against mass radiation exposure in a terrorist attack.
Partnering to Advance Therapy for Radiation Exposure
SRI is developing a method to enable rapid, large-scale response to a bioterrorism threat or an infectious disease epidemic.